No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
US OptionsDetailed Quotes
DXCM241213P75000
- 0.04
- -0.10-71.43%
15min DelayTrading Dec 11 13:04 ET
0.07High0.04Low
0.07Open0.14Pre Close17 Volume137 Open Interest75.00Strike Price86.00Turnover51.09%IV7.01%PremiumDec 13, 2024Expiry Date0.00Intrinsic Value100Multiplier2DDays to Expiry0.04Extrinsic Value100Contract SizeAmericanOptions Type-0.0323Delta0.0232Gamma2015.25Leverage Ratio-0.0360Theta-0.0001Rho-65.19Eff Leverage0.0044Vega
Intraday
- 5D
- Daily
News
10 BofA U.S. Options Overwriting Ideas
Unusual Options Activity: ACI, FTI and Others Attract Market Bets, ACI V/OI Ratio Reaches 75.0
EST Dec 11th Morning Delivery - In the last two hours of trading, 9 options with a high V/OI ratio were detected. With the market volatile, it's crucial to stay informed on the latest options trends.
DexCom Is Maintained at Overweight by Wells Fargo
Wells Fargo Maintains DexCom(DXCM.US) With Buy Rating, Raises Target Price to $94
Express News | Dexcom Inc : Citigroup Raises Target Price to $91 From $85
Express News | Dexcom, Inc. : Wells Fargo Raises Target Price to $94 From $90